feed,title,long_url,short_url
Benzinga,Decision On Kadmon's Belumosudil US Application In Chronic GVHD Pushed Back By Three Months,https://benzinga.com/general/biotech/21/03/20115719/decision-on-kadmons-belumosudil-us-application-in-chronic-gvhd-pushed-back-by-three-months,https://j.mp/3l4nm6R
